Remove Financial Market Remove Medicine Remove Planning
article thumbnail

2025 Q1 Update: Federal Reserve Rates, Inflation and Financial Markets

Your Richest Life

Here are some of the main financial headlines so far, and what they might mean for you: Federal Reserve Holds 2025 Rates Steady At the Feds end of January meeting, they opted to keep the federal rates where they are instead of implementing another cut. Currently, the federal funds rate is at 4.25 percent to 4.50

article thumbnail

Fundamental Analysis Of Tata Chemicals – Financials, Future Plans & More

Trade Brains

After this, we’ll quickly move through the financials of the stock. A highlight of the future plans of the company and a summary conclude the article at the end. Excluding table salt, other chemicals find their end applications in the manufacturing of glass, paper products, medicines & drugs, and more. 25,395 EPS ₹90.90

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Cipla Vs Dr. Reddy’s Laboratories – Financials, Future Plans & More

Trade Brains

It is the world’s largest supplier of generic medicine, in terms of volume with a 20% market share. According to the Economic Survey 2023, India’s domestic pharmaceutical market was estimated at $41 billion. We will understand which drug market they cater to, and what opportunities lay ahead for them.

article thumbnail

Fundamental Analysis Of Divis Laboratories – Profitability & More

Trade Brains

Overview: Indian Pharmaceutical Industry When you consume medicine for certain ailments and diseases, you’re recommended by your doctor to consume it for its curing effect. As per the company’s annual report, they have 42 process patents and plans to expand to meet the growing demand for APIs in the near future. FY 19 0.015 531.02

article thumbnail

Fundamental Analysis of Glenmark Life Sciences – Future Plans & More

Trade Brains

After that, we’ll race through the financials of the stock. A highlight of the R&D spending, future plans and a summary conclude the article at the end. Glenmark plans to commission the recently finished 240 KL CAPEX project for its API and Oncology facility soon. So without further ado, let us jump in. 6,950 EPS 38.00

article thumbnail

Fundamental Analysis Of Lupin – Industry Analysis and Financials

Trade Brains

Fundamental Analysis Of Lupin : Medicines are substances that can be used to prevent, treat, or cure disease. Pharmaceutical companies in India have come a long way in supplying medicines, and with more research, they are improving their products. Segment Analysis The company’s revenue was Rs. crore in FY23. P/E (TTM) 48.09

article thumbnail

Motel 6 or Four Seasons? Preparing, Not Panicking, for Retirement

Investing Caffeine

Many Americans spend more time planning a vacation than they do preparing for retirement or planning their finances. If you are close to retirement, and you have too much exposure to equities, a retrenchment in the stock market could delay your retirement plans by years. Risk Tolerance: What is your asset allocation?